Cargando…
Bringing New PET Drugs to Clinical Practice - A Regulatory Perspective
The regulatory framework for radioactive drugs, in particular those used in positron emission tomography (PET) scans, has been gradually established since the release of the Food and Drug Administration Modernization Act in 1997. Various guidances specially tailored to accommodate special properties...
Autor principal: | Hung, Joseph C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841338/ https://www.ncbi.nlm.nih.gov/pubmed/24312157 http://dx.doi.org/10.7150/thno.5513 |
Ejemplares similares
-
Bringing a genomic perspective to the safety of drug treatment in oncology
por: Innocenti, Federico
Publicado: (2017) -
Bringing microbiome-drug interaction research into the clinic
por: Guthrie, Leah, et al.
Publicado: (2019) -
Bringing New Methods to the Seed Proteomics Platform: Challenges and Perspectives
por: Smolikova, Galina, et al.
Publicado: (2020) -
New Drugs Bringing New Challenges to AML: A Brief Review
por: Yeoh, Zhi Han, et al.
Publicado: (2021) -
Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Patient’s Perspective
por: Mathur, Soania, et al.
Publicado: (2021)